Experimental Neurobiology · 2022 · 10 citations · 9 references
MedicineInfectious DiseasesNeuroscienceMolecular NeuroscienceNeuro-oncologyNeuroinfectious DiseasesBlood-brain Barrier BiologyBlood-brain Barrier DysfunctionBlood-brain Barrier PenetrationBrain TumorsCentral Nervous System InfectionsNeuroinflammationBlood-brain Barrier PathologyBlood-brain Barrier PermeabilityCytokine-mediated Barrier DisruptionCytokine-mediated Barrier InjuryInflammation-mediated Bbb TransportPathogen Entry Across The Blood-brain BarrierPro-inflammatory Mediator ProductionSars-cov-2 Infection
Transsynaptic transport is the most accepted proposal to explain the SARS-CoV-2 infection of the CNS. Nevertheless, emerging evidence shows that neurons do not express the SARS-CoV-2 receptor ACE2, which highlights the importance of the blood-brain barrier (BBB) in preventing virus entry to the brain. In this study, we examine the presence of SARS-CoV-2 messenger ribonucleic acid (mRNA) and the cytokine profile in cerebrospinal fluids (CSF) from two patients with a brain tumor and COVID-19. To determine the BBB damage, we evaluate the Q- albumin index, which is an indirect parameter to assess the permeability of this structure. The Q-albumin index of the patient with an intraventricular brain tumor suggests that the BBB is undamaged, preventing the passage of SARS-CoV-2 and pro-inflammatory molecules. The development of brain tumors that disrupt the BBB (measured by the Q-albumin index), in this case, a petroclival meningioma (Case 1), allows the free passage of the SARS-CoV-2 virus and probably lets the free transit of pro-inflammatory molecules to the CNS, which leads to a possible activation of the microglia (astrogliosis) and an exacerbated immune response represented by IL-13, IFN-γ, and IL-2 trying to inhibit both the infection and the carcinogenic process.
9
IL-13 is a driver of COVID-19 severity
Alexandra N. Donlan, Chelsea Marie, Benjamin T. Bradley et al. · JCI Insight · 2021 · 163 citations · Full text
Mathilde Bellon, Cecilia Schweblin, Nathalie Lambeng et al. · Clinical Infectious Diseases · 2020 · 97 citations · Full text